Article

The Effects of Chemotherapeutic Drugs on PD-L1 Gene Expression in Breast Cancer Cell Lines

2021-07-14

Abstract excerpt

<title>Abstract</title> <p>Breast cancer is the most common cancer among women in terms of prevalence and mortality, and chemotherapy is one of the most effective treatments at higher stages. However, resistance to chemotherapy is the main obstacle in the treatment of this cancer. Accumulated evidence identified the PD-L1 protein as an essential protein in the development of different cancers. Abnormal expression...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 84cd5ef3-0e37-5715-99cd-460f9f7b1ea7
DOI: 10.21203/rs.3.rs-682668/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Effects of Chemotherapeutic Drugs on PD-L1 Gene Expression in Breast Cancer Cell LinesDOI 10.21203/rs.3.rs-682668/v1Read

Chemotherapeutic Agents Increase PD-L1 Expression in A549 Lung Cancer Cell LineSemantic proximity Read

Predictive Role of Peripheral Blood Lymphocyte And Cytokine Phenotypes in Patients with Operable Breast Cancer And Neoadjuvant Therapy: A Preliminary StudySemantic proximity Read

Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)Semantic proximity Read

Systematic Identification of the Cancer Pathways and Molecules Related With Breast Cancer ImmunogenicitySemantic proximity Read

Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant settingSemantic proximity Read

PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancerSemantic proximity Read

Genomic alteration profile and PD-L1 expression among different breast cancer subtypes in Chinese population and their correlations.Semantic proximity Read

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome DataSemantic proximity Read

MCT4 Upregulates PD-L1 Expression and Defines Novel Composite Therapeutic Targets for Triple-Negative Breast CancerSemantic proximity Read

Crosstalk between miRNAs and signaling pathways in the development of drug resistance in breast cancerSemantic proximity Read

Complex regulatory network of programmed death-ligand 1 in cancer: Cancer immunomodulation from molecular mechanisms to clinical applicationsSemantic proximity Read

ABCB1 regulates myeloid-derived suppressor cells-related immune factors in breast cancerSemantic proximity Read